Seffalair Spiromax 113/14 mcg, Multidosenpulverinhalator

7680678910028 CH-67891 Multidosenpulverinhalator

Associated product:

SEFFALAIR SPIROMAX pdr inh 113/14 mcg 60 dos
Seffalair Spiromax 113/14 mcg, Multidosenpulverinhalator
Seffalair Spiromax 113/14 mcg, Multidosenpulverinhalator
1 / 2
google

Article details

Package size
60
Selling units
60
Measure
Stück
Galenic form
Multidosenpulverinhalator
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/10/2022
Patient information leaflet
Français
28/10/2022
Patient information leaflet
Italien
28/10/2022
Summary of Product Characteristics
Allemand
28/10/2022
Summary of Product Characteristics
Français
28/10/2022
Summary of Product Characteristics
Italien
28/10/2022

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 UG Substance Wirkstoff (Principe actif)
(N/A)
12.75 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 57.05
Specialties list
Yes
Generic
No
SL addition date: 01/10/2021

Authorization holder

Teva Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
67891
Drug name
Seffalair Spiromax, Multidosenpulverinhalator
Galenic form
PULIN
ATC Code
R03AK06
Authorization status
Z
Dispensing category
B
First authorization
12/04/2021
Authorization expiration date
31/12/9999
IT Number
03.04.3.
Domain
Human medicine
Field of application
Asthma

Package details

Description (FR)
SEFFALAIR SPIROMAX pdr inh 113/14 mcg 60 dos
Description (DE)
SEFFALAIR SPIROMAX Inh Plv 113/14 mcg 60 Dos
Market launch
12/04/2021
Narcotic (BTM)
No

Other package sizes (2)

SEFFALAIR SPIROMAX pdr inh 55/14 mcg 60 dos
60 STU
GTIN: 7680678910011
View
SEFFALAIR SPIROMAX pdr inh 232/14 mcg 60 dos
60 STU
GTIN: 7680678910035
View